NASDAQ:ASRT

Assertio Therapeutics Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy ASRT

*Your capital is at risk

$23.47

+0.0200 (+0.0853%)

At Close: Jun 03, 2026

Assertio Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 97.05. In total, the insiders bought 4.33M and sold 251.96K ASRT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	97.05
● Buy	4.33M shares
● Sell	251.96K shares
77% Buy Activity Moderate Negative Correlation
Sell Signal Low Confidence May 13, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 97.05. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 07, 2025 Buy	Stock Option (right to buy) A-Award	Mckee William Director	Director	81 225 Value: $50.1K
May 07, 2025 Buy	Common Stock A-Award	Mason Heather L Director	Director	53 750 Value: $33.2K
May 07, 2025 Buy	Stock Option (right to buy) A-Award	Mason Heather L Director	Director	81 225 Value: $50.1K
May 07, 2025 Buy	Stock Option (right to buy) A-Award	Mason Heather L Director	Director	81 225 Value: $50.1K
May 07, 2025 Buy	Common Stock A-Award	Mason Heather L Director	Director	53 750 Value: $33.2K
May 07, 2025 Buy	Stock Option (right to buy) A-Award	Mckee William Director	Director	81 225 Value: $50.1K
May 07, 2025 Buy	Common Stock A-Award	Mckee William Director	Director	53 750 Value: $33.2K
May 07, 2025 Buy	Stock Option (right to buy) A-Award	Emany Sravan Kumar Director	Director	81 225 Value: $50.1K
May 07, 2025 Buy	Common Stock A-Award	Emany Sravan Kumar Director	Director	53 750 Value: $33.2K
May 07, 2025 Buy	Stock Option (right to buy) A-Award	Kirk Sigurd Director	Director	81 225 Value: $50.1K
May 07, 2025 Buy	Common Stock A-Award	Kirk Sigurd Director	Director	53 750 Value: $33.2K
May 07, 2025 Buy	Stock Option (right to buy) A-Award	Stark David Matthew Director	Director	81 225 Value: $50.1K
May 07, 2025 Buy	Common Stock A-Award	Stark David Matthew Director	Director	53 750 Value: $33.2K
Feb 21, 2025 Buy	Common Stock M-Exempt	Schlessinger Sam SVP, General Counsel	Officer	17 150 Value: $13.9K
Feb 21, 2025 Sell	Common Stock F-InKind	Schlessinger Sam SVP, General Counsel	Officer	7 656 Value: $6K
Feb 21, 2025 Buy	Restricted Stock Units M-Exempt	Schlessinger Sam SVP, General Counsel	Officer	17 150 Value: $13.9K
Feb 21, 2025 Buy	Common Stock M-Exempt	Schwichtenberg Paul See Remarks	Officer	17 150 Value: $13.9K
Feb 21, 2025 Sell	Common Stock F-InKind	Schwichtenberg Paul See Remarks	Officer	8 505 Value: $7K
Feb 21, 2025 Buy	Restricted Stock Units M-Exempt	Schwichtenberg Paul See Remarks	Officer	17 150 Value: $13.9K
Feb 21, 2025 Buy	Common Stock M-Exempt	Patel Ajay SVP And CFO	C-Suite Officer	17 150 Value: $13.9K
Feb 21, 2025 Sell	Common Stock F-InKind	Patel Ajay SVP And CFO	C-Suite Officer	8 505 Value: $7K
Feb 21, 2025 Buy	Restricted Stock Units M-Exempt	Patel Ajay SVP And CFO	C-Suite Officer	17 150 Value: $13.9K
Feb 21, 2025 Buy	Common Stock M-Exempt	Schwichtenberg Paul See Remarks	Officer	17 150 Value: $13.9K
Feb 21, 2025 Buy	Restricted Stock Units M-Exempt	Schlessinger Sam SVP, General Counsel	Officer	17 150 Value: $13.9K
Feb 21, 2025 Sell	Common Stock F-InKind	Schlessinger Sam SVP, General Counsel	Officer	7 656 Value: $6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ASSERTIO THERAPEUTICS INC.

Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, ...

Read Full Profile Here